Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison by CNBC Markets | April 2, 2026 6:10 pm | US Markets Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.
